follow us in feedly
Target Stock News

Join Our Community

Facebook

Twitter

RSS

      • Tech
        • Application Software
        • Communications
        • Computer Hardware
        • Online Media
        • Semiconductors
      • Consumer
        • Autos
        • Beverages
        • Consumer Packaged Goods
        • Entertainment
        • Manufacturing
        • Restaurants
        • Retail
        • Travel & Leisure
      • Financial
        • Asset Management
        • Banks
        • Brokers & Exchanges
        • Credit Services
        • Insurance
      • Politics
        • Trump
        • US Budget
      • Health
        • Healthcare
        • Biotechnology
        • Drug Manufacturers
        • Pharmaceutical
      • Basic Materials
        • Agriculture
        • Metals & Mining
          • Cobalt
          • Zinc
          • Gold
          • Silver
          • Lithium
          • Uranium
          • Copper
      • Energy
        • Oil & Gas
        • Alternative Energy
          • Biofuels
          • Hydro
          • Solar
      • Industrials
        • Aerospace and Defense
        • Airlines
        • Business Services
        • Consulting and Outsourcing
        • Farm & Construction Machinery
        • Industrial Products
        • Transportation & Logistics
      HomeHealthBiotechnology

      Biotechnology

      RETA stock
      Biotechnology

      RETA Stock Soars 157% in a Month: Are You Excited?

      Nov 12 Ankit Singhania

      RETA stock has soared over 155% over the past month on multiple news from Reata Pharmaceuticals Inc (NASDAQ:RETA).

      Many pharmaceutical stocks have enjoyed significant gains this year, but there are very few stocks …

      Read

      BGNE stock
      Biotechnology

      BGNE Stock Soars After Amgen Invests $2.7B in BeiGene

      Nov 1 Ankit Singhania

      BGNE stock is on roll after Amgen Inc. (NASDAQ:AMGN) announced that it is investing around $2.7 billion in Chinese biotech company BeiGene Ltd (NASDAQ:BGNE). The company will take a 20.5% stake in the drug developer. …

      Read

      ACAD stock
      Biotechnology

      ACAD Stock Hits Multi-Year Highs on Impressive Data

      Sep 9 Ankit Singhania

      ACAD stock is the biggest biotech stock gainer in Monday’s session after ACADIA Pharmaceuticals (NASDAQ:ACAD) announced successful results in its Phase 3 clinical trial of HARMONY.

      Big Relief for Investors

      When a pharmaceutical …

      Read

      ACAD stock
      Biotechnology

      ACAD Stock Slumps to 5-Month Low on Schizophrenia Setback

      Jul 23 Ankit Singhania

      ACAD stock is taking a major hit today, slumping to a new 5-month low after Acadia Pharmaceuticals Inc (NASDAQ:ACAD)’s schizophrenia treatment did not pass a late-stage clinical trial.

      Disappointing News

      Clinical trials are …

      Read

      AMRN stock
      Biotechnology

      AMRN Stock Rockets 13% As Amarin Sees Strong Revenues

      Jul 2 Ankit Singhania

      AMRN has been on a tear on Tuesday and has gone up by as much as 13% as Amarin Corporation plc (NASDAQ:AMRN) raised its projections for the company’s revenues for the year 2019.

      Revenue … Read

      ARRY stock
      Biotechnology

      ARRY Stock Hits All-Time High on Pfizer’s Acquisition

      Jun 17 Ankit Singhania

      ARRY stock is witnessing a solid day after Pfizer Inc (NYSE:PFE) announced it was acquiring Array Biopharma Inc (NASDAQ:ARRY).

      62% Premium on ARRY Stock

      In a significant development, pharmaceutical giant Pfizer has decided …

      Read

      Advaxis
      Biotechnology

      Advaxis Shares Pop Up 72% On Solid Data For ADXS-NEO

      Apr 1 Ankit Singhania

      Shares of Advaxis (NASDAQ:ADXS) are up a whopping 72%, selling for $10.20 this morning after the company released improved data for its personalized cancer vaccine candidate ADXS-NEO.

      The stock is up about 32% …

      Read

      Biogen Alzheimer's drug trial
      Biotechnology

      Biogen Alzheimer’s Drug Trial Sees Positive Results, Shares Soar 20%

      Jul 6 Caroline Harris

      Biogen Alzheimer’s Drug Trial: Finding a cure for Alzheimer’s disease can look like an impossible mission, even for the most brilliant minds. What isn’t impossible, however, is offering disease-modifying therapies to those suffering from the …

      Read

      Auris Health
      Biotechnology

      Auris Health – Monarch Platform Will Revolutionize Medical Intervention

      Mar 29 Nicky Toor

      Silicon Valley-based Auris Health Inc., formerly Auris Surgical Robotics Inc., announced that the company’s Monarch Platform has received clearance from the US Food and Drug Administration.

      The platform received clearance for diagnostic and …

      Read

      Spark Therapeutics
      Biotechnology

      Spark Therapeutics Shares Plunged More Than 40% Today, Here’s Why

      Dec 11 Caroline Harris

      On Monday, in early trade, Spark Therapeutics, Inc. (NASDAQ:ONCE) saw its shares plunge more than 40%.

      What happened? Well, the decline started after the gene therapy biotech company disclosed data from various trials …

      Read

      Posts navigation

      1 2 … 7 »

      YOU MAY ALSO LIKE

      • DIS stock
        DIS Stock Hits All-Time High on Launch of Disney+
        Nov 14 Caileam Raleigh
      • CSCO stock
        CSCO Stock Plunges 7% Following Uninspiring Q2 Sales Forecast
        Nov 14 Ankit Singhania
      • AMZN Stock
        AMZN Stock Down as Nike Ends Direct Selling to Online Retailer
        Nov 13 Caileam Raleigh
      • NVDA stock
        NVDA Stock Hovers Around 52-Week High Ahead of Q3 Earnings
        Nov 13 Ankit Singhania
      • BA Stock
        BA Stock Down as Boeing 737 MAX Orders Continue to Fall
        Nov 12 Caileam Raleigh
      Subscribe & Get The LATEST Stock Pick Alerts
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2023 | #764 - 1055 Dunsmuir Street. Vancouver, BC, Canada V7X 1L3 | 1-866-773-3540

      Copyright © 2023 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #764 - 1055 Dunsmuir Street. Vancouver, BC, Canada V7X 1L3 | 1-866-773-3540